Loading candles…
Incorporated in 1984, Panacea Biotec Ltd is a research-driven company operating in the biotechnology, pharmaceuticals, and health management industries. It focuses on the development, manufacturing, and marketing of vaccines, pharmaceutical formulations, and nutrition products. The company leverages R&D-led innovation and maintains cGMP-compliant manufacturing facilities, which are qualified by global regulatory authorities including the US FDA, WHO PQ, and EMA. Panacea Biotec holds a leading position in the Indian vaccine market and exports its products to more than 50 countries worldwide. With over 30 years of operational history, it integrates biotechnology and health management through its product offerings, serving primarily the Indian market and a broad international footprint.
This page is a live market overview for PANACEA BIOTEC LTD (PANACEABIO) on the NSE. As a listed security, PANACEA BIOTEC LTD is tracked in the Healthcare segment of the Indian cash market and is widely followed for price discovery, liquidity and sector exposure. Use this overview to review price action, session ranges and derivatives context for PANACEABIO before placing trades on tick2trade.
As of the latest feed, PANACEABIO last traded at ₹413 on NSE, down ₹5.65 (1.35%) from the previous close of ₹418.65. Today's session range is ₹410.35 – ₹423.95, against a 52-week band of ₹292.4 – ₹647. Traded volume today stands at 1.45L shares.
The overview consolidates an interactive price chart with multiple time ranges, recent market headlines, upcoming corporate events for PANACEABIO in one place so you do not need multiple screens during the session. Day and 52-week ranges help you judge whether PANACEABIO is trading near support, resistance or the middle of its recent band. Volume and depth, when available, add context on how aggressively the name is being bought or sold.
Equity overview pages are built for investors who want a single reference for PANACEA BIOTEC LTD before reading news, checking results or sizing a position. Corporate events and headlines in the side column surface catalysts that may explain sudden moves in PANACEABIO. Related stocks in the same sector appear at the bottom of the page for quick peer comparison.
For a full option chain with greeks, open-interest bias, max pain and multi-leg strategy tools, open the tick2trade terminal or visit the dedicated PANACEABIO option chain page linked from this overview.
| Type | Details | Date |
|---|---|---|
| Results - FY26 | PANACEABIO : 30-May-2026 : The Company has informed the Exchange that a Board meeting to be held on May 29, 2026 has been re-scheduled. Further, the Company… | 30 May 2026 |
| Results - FY26 | To consider and approve the financial results for the period ended March 31, 2026 and dividend | 29 May 2026 |
| Results - FY25 | To consider and approve the financial results for the period ended December 31, 2025 | 11 Feb 2026 |
| Unaudited Results - Q2 & FY25 | To consider and approve the unaudited financial results for the quarter and half year ended September 30, 2025 | 14 Nov 2025 |
| Results - FY25 | To consider and approve the financial results for the period ended Jun 30, 2025 | 14 Aug 2025 |
| Results - FY25 | To consider and approve the financial results for the period ended March 31, 2025 and passing over of dividend on equity as well as preference shares for the… | 30 May 2025 |
Tick2trade is a brand/platform owned and operated by Besseggen InfoTech LLP, a SEBI Registered Stock Broker holding Registration No: INZ000213450, Member of NSE (Member Code: 90155) and BSE (Member Code: 6722). Investment in securities market are subject to market risks; read all related documents carefully before investing.